Xavier Montalbán Selected Research

Xavier Montalbán Research Topics

22	Multiple Sclerosis 05/2024 - 02/2005
2	Relapsing-Remitting Multiple Sclerosis 10/2014 - 06/2014
1	Epstein-Barr Virus Infections 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Rheumatoid Arthritis 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Immune System Diseases (Immune Disorders) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020
1	Ankylosing Spondylitis 01/2020
1	Uveitis 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Psoriatic Arthritis 01/2020
1	Listeriosis (Listeria Infection) 01/2019
1	Chronic Progressive Multiple Sclerosis 08/2014
1	Inflammation (Inflammations) 08/2014
1	Disease Progression 08/2014

9	Interferon beta-1b (Betaseron)FDA Link 01/2020 - 02/2005
3	Biomarkers (Surrogate Marker)IBA 11/2015 - 06/2014
2	ozanimodIBA 10/2022 - 01/2019
2	Vitamin D FDA LinkGeneric 01/2020 - 03/2014
2	InterferonsIBA 01/2019 - 06/2014
2	AntibodiesIBA 01/2019 - 06/2014
2	Interferon-betaIBA 08/2007 - 02/2005
1	Dimethyl FumarateIBA 01/2023
1	teriflunomideIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	InterleukinsIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Alemtuzumab (Campath)FDA Link 01/2019
1	SodiumIBA 07/2017
1	SaltsIBA 07/2017
1	CotinineIBA 11/2015
1	Immunoglobulin G (IgG)IBA 11/2015
1	Glatiramer Acetate (Copaxone)FDA Link 10/2014
1	hydroxide ionIBA 08/2014
1	25-hydroxyvitamin DIBA 08/2014
1	Oligoclonal BandsIBA 08/2014
1	Immunoglobulin M (IgM)IBA 08/2014
1	Natalizumab (Tysabri)FDA Link 04/2014
1	Mitoxantrone (Novantrone)FDA LinkGeneric 11/2009
1	Neutralizing AntibodiesIBA 02/2005